Evidence map›Paper›PMID 24811249›Full record

ArticlePloS one2014

The inhibition of the dorsal paragigantocellular reticular nucleus induces waking and the activation of all adrenergic and noradrenergic neurons: a combined pharmacological and functional neuroanatomical study.

Olivier Clément, Sara Valencia Garcia, Paul-Antoine Libourel, Sébastien Arthaud, Patrice Fort, Pierre-Hervé Luppi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Adrenergic C1 neurons enhance anxiety via projections to PAG.bioRxiv : the preprint server for biology · 2024
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Locus Coeruleus Phasic, But Not Tonic, Activation Initiates Global Remapping in a Familiar Environment.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Olivier ClémentINSERM, U1028; CNRS, UMR5292; Lyon Neuroscience Research Center, Team SLEEP, Lyon, France; University Claude Bernard Lyon 1, Lyon, France.
Sara Valencia GarciaINSERM, U1028; CNRS, UMR5292; Lyon Neuroscience Research Center, Team SLEEP, Lyon, France; University Claude Bernard Lyon 1, Lyon, France.
Paul-Antoine LibourelINSERM, U1028; CNRS, UMR5292; Lyon Neuroscience Research Center, Team SLEEP, Lyon, France; University Claude Bernard Lyon 1, Lyon, France.
Sébastien ArthaudINSERM, U1028; CNRS, UMR5292; Lyon Neuroscience Research Center, Team SLEEP, Lyon, France; University Claude Bernard Lyon 1, Lyon, France.
Patrice FortINSERM, U1028; CNRS, UMR5292; Lyon Neuroscience Research Center, Team SLEEP, Lyon, France; University Claude Bernard Lyon 1, Lyon, France.
Pierre-Hervé LuppiINSERM, U1028; CNRS, UMR5292; Lyon Neuroscience Research Center, Team SLEEP, Lyon, France; University Claude Bernard Lyon 1, Lyon, France.
Centre de Recherche en Neurosciences de Lyon · FRInserm · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GABAergic neurons specifically active during paradoxical sleep (PS) localized in the dorsal paragigantocellular reticular nucleus (DPGi) are known to be responsible for the cessation of activity of the noradrenergic neurons of the locus coeruleus during PS. In the present study, we therefore sought to determine the role of the DPGi in PS onset and maintenance and in the inhibition of the LC noradrenergic neurons during this state. The effect of the inactivation of DPGi neurons on the sleep-waking cycle was examined in rats by microinjection of muscimol, a GABAA agonist, or clonidine, an alpha-2 adrenergic receptor agonist. Combining immunostaining of the different populations of wake-inducing neurons with that of c-FOS, we then determined whether muscimol inhibition of the DPGi specifically induces the activation of the noradrenergic neurons of the LC. Slow wave sleep and PS were abolished during 3 and 5 h after muscimol injection in the DPGi, respectively. The application of clonidine in the DPGi specifically induced a significant decrease in PS quantities and delayed PS appearance compared to NaCl. We further surprisingly found out that more than 75% of the noradrenergic and adrenergic neurons of all adrenergic and noradrenergic cell groups are activated after muscimol treatment in contrast to the other wake active systems significantly less activated. These results suggest that, in addition to its already know inhibition of LC noradrenergic neurons during PS, the DPGi might inhibit the activity of noradrenergic and adrenergic neurons from all groups during PS, but also to a minor extent during SWS and waking.

Indexed as

NeuroanatomyAdrenergic NeuronsAnimalsClonidineMedulla OblongataMuscimolProto-Oncogene Proteins c-fosRatsSleep, REMWakefulnessClonidineMuscimolProto-Oncogene Proteins c-fos

Identifiers

PMID24811249
PMCPMC4014589
OpenAlexW2085048990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.